Literature DB >> 12913405

Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use.

Jim Edward Weber1, Judd E Hollander, Sabina A Murphy, Eugene Braunwald, C Michael Gibson.   

Abstract

BACKGROUND: Numerous factors have been implicated in the pathogenesis of cocaine associated myocardial infarction (CAMI). However, the relative contributions each of these mechanisms provide to the pathogenesis of CAMI have not been well defined. We hypothesized that significant angiographic differences exist between CAMI patients vs thrombotic AMI patients (TAMI) and normal controls.
METHODS: The TIMI Flow Grade, corrected TIMI Frame Count (CTFC), TIMI Myocardial Perfusion Grade (TMPG), presence of triple-vessel disease, stenosis severity, and presence of angiographically apparent thrombus were compared in patients who sustained CAMI to TAMI patients and normal controls.
RESULTS: 2495 angiograms were analyzed (CAMI = 57, TAMI = 2403, Controls = 35). Impairment in both epicardial and microvascular flow in patients with CAMI was intermediate between TAMI and controls. Compared to TAMI patients, CAMI patients were less likely to have 3 vessel disease (8.9% vs. 19.1%; p < 0.05), epicardial stenosis was less severe (14.9+/-30.2 vs. 72.6+/-18.6; p < 0.0001), less thrombus was present (6.5% vs. 33.1%; p < 0.001) and TIMI grade 3 flow was observed more frequently (76% vs. 59%). Normal TMPG 3 perfusion was significantly impaired in both CAMI and TAMI patients when compared to controls without AMI (TMPG 3 was 40% and 26.6% vs. 100% respectively; p < 0.001 for both). The majority of patients in both AMI groups had diminished or absent tissue level perfusion (TMPG 0 flow, CAMI 53.9 vs. TAMI 56.8%).
CONCLUSIONS: Both epicardial and microvascular flow is impaired in CAMI. While epicardial flow among CAMI patients is slightly better than TAMI patients, the incidence of little or severely impaired tissue level perfusion is nearly identical.

Entities:  

Mesh:

Year:  2002        PMID: 12913405     DOI: 10.1023/a:1025056912284

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  31 in total

1.  TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.

Authors:  C P Cannon; C M Gibson; C H McCabe; A A Adgey; M J Schweiger; R F Sequeira; G Grollier; R P Giugliano; M Frey; H S Mueller; R M Steingart; W D Weaver; F Van de Werf; E Braunwald
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

2.  Triggering of myocardial infarction by cocaine.

Authors:  M A Mittleman; D Mintzer; M Maclure; G H Tofler; J B Sherwood; J E Muller
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

3.  Relation of acute myocardial infarction to cocaine abuse.

Authors:  L L Cregler; H Mark
Journal:  Am J Cardiol       Date:  1985-11-01       Impact factor: 2.778

4.  Cocaine-associated chest pain: how common is myocardial infarction?

Authors:  J E Weber; C R Chudnofsky; M Boczar; E W Boyer; M D Wilkerson; J E Hollander
Journal:  Acad Emerg Med       Date:  2000-08       Impact factor: 3.451

5.  TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.

Authors:  C P Cannon; C H McCabe; C M Gibson; M Ghali; R F Sequeira; G R McKendall; J Breed; N B Modi; N L Fox; R P Tracy; T W Love; E Braunwald
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

6.  Cocaine and sudden "natural" death.

Authors:  R E Mittleman; C V Wetli
Journal:  J Forensic Sci       Date:  1987-01       Impact factor: 1.832

7.  Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group.

Authors:  J E Hollander; R S Hoffman; P Gennis; P Fairweather; M J DiSano; D A Schumb; J A Feldman; S S Fish; S Dyer; P Wax
Journal:  Acad Emerg Med       Date:  1994 Jul-Aug       Impact factor: 3.451

8.  Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment.

Authors:  G Togna; E Tempesta; A R Togna; N Dolci; B Cebo; L Caprino
Journal:  Haemostasis       Date:  1985

9.  Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis.

Authors:  D J Moliterno; R A Lange; R D Gerard; J E Willard; C Lackner; L D Hillis
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

10.  Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts.

Authors:  F A Dressler; S Malekzadeh; W C Roberts
Journal:  Am J Cardiol       Date:  1990-02-01       Impact factor: 2.778

View more
  3 in total

Review 1.  Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.

Authors:  Vijayalakshmi Kunadian; Caitlin Harrigan; Cafer Zorkun; Alexandra M Palmer; Katherine J Ogando; Leah H Biller; Erin E Lord; Scott P Williams; Michelle E Lew; Lauren N Ciaglo; Jacqueline L Buros; Susan J Marble; William J Gibson; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-04-20       Impact factor: 2.300

2.  Coronary computerized tomography angiography for rapid discharge of low-risk patients with cocaine-associated chest pain.

Authors:  Kristy Walsh; Anna Marie Chang; Jeanmarie Perrone; Christine McCusker; Frances Shofer; Mark Collin; Harold Litt; Judd Hollander
Journal:  J Med Toxicol       Date:  2009-09

Review 3.  Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications.

Authors:  Yufeng Wei; Rameen Shah
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.